Herbalife's earnings surpass expectations and receive investment from Cristiano Ronaldo, causing the stock price to soar 12%

LootboxPhobia · 2026-02-19T01:57:38+00:00

Herbalife's Q4 earnings exceeded expectations, with a earnings per share of $0.45 and revenue reaching $1.28 billion, causing the stock price to rise by 12.2%. Additionally, football star Cristiano Ronaldo invested $7.5 million in Herbalife's personalized nutrition platform, demonstrating his confidence in the company. The company expects net sales growth between 1% and 6% by 2026.

LootboxPhobia

2026-02-19 01:57:38

Abstract generation in progress

Investing.com – Herbalife Nutrition Ltd. (NYSE:HLF) stock surged 12.2% in after-hours trading on Wednesday after the nutritional company reported better-than-expected fourth-quarter results and announced a $7.5 million investment from soccer superstar Cristiano Ronaldo (C罗).

The company reported adjusted fourth-quarter earnings of $0.45 per share, surpassing analyst expectations of $0.43, with revenue reaching $1.28 billion, above the market consensus of $1.25 billion. Fourth-quarter sales increased 6.3% year-over-year, or 5.5% at constant currency.

CEO Stephan Gratziani stated, “We closed 2025 on a strong note, with net sales growth and adjusted EBITDA exceeding guidance for both the fourth quarter and the full year. Cristiano Ronaldo’s investment in Pro2col reflects our shared vision of expanding personalized nutrition and health on a global scale.”

The stock price jump followed news that Ronaldo acquired a 10% stake in HBL Pro2col Software, LLC for $7.5 million and secured sponsorship rights. This investment highlights Ronaldo’s commitment to Herbalife’s personalized nutrition technology platform.

For the full year 2025, Herbalife’s net sales totaled $5 billion, up 0.9% from 2024, or 2.5% at constant currency. The company’s full-year adjusted EBITDA was $657.6 million, with a profit margin of 13.1%, an increase of 40 basis points from 2024.

Regional performance varied, with Latin America performing strongly in the fourth quarter with a 17.6% increase, while North America declined slightly by 0.8%. The company’s EMEA region grew 9.2%, and Asia-Pacific increased 4.9%.

Looking ahead, Herbalife provided guidance for the first quarter of 2026, expecting net sales growth of 3.0% to 7.0% year-over-year, and full-year 2026 net sales growth of 1.0% to 6.0%.

Chief Financial Officer John DeSimone said, “Our results reflect strong operational and financial momentum.” He noted that the company achieved its second consecutive year of adjusted EBITDA margin expansion while reducing debt.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes